Elbit Med Tech (EMTC) - Net Assets

Latest as of December 2022: ILA25.01 Million ILA ≈ $67.05K USD

Based on the latest financial reports, Elbit Med Tech (EMTC) has net assets worth ILA25.01 Million ILA (≈ $67.05K USD) as of December 2022. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA25.53 Million ≈ $68.45K USD) and total liabilities (ILA522.00K ≈ $1.40K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check EMTC cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	ILA25.01 Million
% of Total Assets	97.96%
Annual Growth Rate	N/A
5-Year Change	N/A
10-Year Change	261.9%
Growth Volatility	606.31

Elbit Med Tech - Net Assets Trend (2008–2022)

This chart illustrates how Elbit Med Tech's net assets have evolved over time, based on quarterly financial data. Also explore Elbit Med Tech asset portfolio for the complete picture of this company's asset base.

Annual Net Assets for Elbit Med Tech (2008–2022)

The table below shows the annual net assets of Elbit Med Tech from 2008 to 2022. For live valuation and market cap data, see EMTC company net worth.

Year	Net Assets	Change
2022-12-31	ILA25.01 Million ≈ $67.05K	-18.09%
2021-12-31	ILA30.53 Million ≈ $81.86K	-33.71%
2020-12-31	ILA46.06 Million ≈ $123.48K	+225.55%
2019-12-31	ILA-36.69 Million ≈ $-98.36K	-136.78%
2018-12-31	ILA-15.49 Million ≈ $-41.54K	+63.44%
2017-12-31	ILA-42.38 Million ≈ $-113.63K	-33.98%
2016-12-31	ILA-31.64 Million ≈ $-84.81K	-136.42%
2015-12-31	ILA-13.38 Million ≈ $-35.87K	-1444.82%
2014-12-31	ILA995.00K ≈ $2.67K	-85.60%
2013-12-31	ILA6.91 Million ≈ $18.53K	+116.93%
2011-12-31	ILA-40.83 Million ≈ $-109.45K	-279.81%
2010-12-31	ILA-10.75 Million ≈ $-28.82K	+92.41%
2009-12-31	ILA-141.63 Million ≈ $-379.72K	-18.08%
2008-12-31	ILA-119.95 Million ≈ $-321.59K	--

Equity Component Analysis

This analysis shows how different components contribute to Elbit Med Tech's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 11692700000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2022)

Component	Amount	Percentage
Other Components	ILA82.68 Million	330.56%
Total Equity	ILA25.01 Million	100.00%

Elbit Med Tech Competitors by Market Cap

The table below lists competitors of Elbit Med Tech ranked by their market capitalization.

Company	Market Cap
VULTUS AB F:V06	$1.37 Million
Frontier Developments Plc LSE:FDEV	$1.37 Million
Greenlite Ventures Inc. NASDAQ:GRNLD	$1.37 Million
Tasfoods Ltd AU:TFL	$1.37 Million
Smartfren Telecom Tbk JK:FREN	$1.36 Million
Luminar Technologies Inc. Class A NASDAQ:LAZRQ	$1.36 Million
Ortin Global Limited NSE:ORTINGLOBE	$1.36 Million
Fuse Cobalt Inc V:FUSE	$1.36 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Elbit Med Tech's equity between the two most recent reporting periods.

Equity Growth Insights

From 2021 to 2022, total equity changed from 30,533,000 to 25,011,000, a change of -5,522,000 (-18.1%).
Net loss of 5,111,000 reduced equity.
Share repurchases of 411,000 reduced equity.

Equity Change Factors (2021 to 2022)

Factor	Impact	Contribution
Net Income	ILA-5.11 Million	-20.44%
Share Repurchases	ILA411.00K	-1.64%
Total Change	ILA-	-18.09%

Book Value vs Market Value Analysis

This analysis compares Elbit Med Tech's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 80.52x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2017-12-31	ILA-0.18	ILA22.20	x
2018-12-31	ILA-0.07	ILA22.20	x
2019-12-31	ILA-0.16	ILA22.20	x
2020-12-31	ILA0.50	ILA22.20	x
2021-12-31	ILA0.36	ILA22.20	x
2022-12-31	ILA0.28	ILA22.20	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Elbit Med Tech utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -20.44%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 0.00%
• Asset Turnover: 0.00x
• Equity Multiplier: 1.02x
Recent ROE (-20.44%) is above the historical average (-76.39%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2008	0.00%	-482.15%	0.38x	0.00x	ILA-105.72 Million
2009	0.00%	-154.17%	0.83x	0.00x	ILA-7.20 Million
2013	-170.08%	0.00%	0.00x	5.89x	ILA-12.45 Million
2014	-942.51%	0.00%	0.00x	33.73x	ILA-9.48 Million
2015	0.00%	0.00%	0.00x	0.00x	ILA-14.19 Million
2016	0.00%	0.00%	0.00x	0.00x	ILA-15.49 Million
2017	0.00%	0.00%	0.00x	0.00x	ILA-6.51 Million
2018	0.00%	0.00%	0.00x	0.00x	ILA28.37 Million
2019	0.00%	0.00%	0.00x	0.00x	ILA-17.55 Million
2020	267.15%	0.00%	0.00x	1.80x	ILA118.44 Million
2021	-50.83%	0.00%	0.00x	1.02x	ILA-18.57 Million
2022	-20.44%	0.00%	0.00x	1.02x	ILA-7.61 Million

Industry Comparison

This section compares Elbit Med Tech's net assets metrics with peer companies in the Healthcare Equipment & Supplies industry.

No peer company data available for comparison.

About Elbit Med Tech

TA:EMTC Israel Healthcare Equipment & Supplies

Market Cap

$5.52 Million

ILA2.06 Billion ILA

Market Cap Rank

#30020 Global

#446 in Israel

Share Price

ILA22.20

Change (1 day)

-7.50%

52-Week Range

ILA18.20 - ILA29.60

All Time High

ILA185.50